RIGL

NASDAQStock

Rigel Pharmaceuticals, Inc.

$25.86-0.74 (-2.78%)

52-Week Range

$16.26

$50.96

Key Stats

Market Cap

469.4M

P/E Ratio

1.33

Dividend Yield

—

Beta

1.17

Volume

203.5K

Avg Volume

471.0K

Performance

-22.27%

-37.38%

-28.69%

YTD

-36.41%

+32.14%

+64.20%

-36.82%

Price Chart

ETF Exposure

RIGL is held by 87 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
VXF	Vanguard Extended Market ETF	0.01%	195,095	$6.8M	$84.10B	0.05%
AVSU	Avantis Responsible U.S. Equity ETF	0.01%	1,135	$31K	$412.5M	0.15%
AVUS	Avantis U.S. Equity ETF	0.01%	16,404	$703K	$10.96B	0.15%
LSLT	Pacer Salt Low truBeta US Market ETF	0.01%	64,624	$2.4M	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.01%	64,624	$2.4M	$6.3M	0.60%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.01%	64,624	$2.4M	$1.0M	0.79%
VETS	Pacer Military Times Best Employers ETF	0.01%	64,624	$2.4M	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.01%	64,624	$2.4M	$3.7M	0.70%
DXUV	Dimensional - US Vector Equity ETF	0.01%	700	$19K	$351.7M	0.28%
SMMD	iShares Russell 2500 ETF	0.00%	6,366	$173K	$2.28B	0.23%
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	2,458	$65K	$2.68B	0.14%
HDG	ProShares - Hedge Replication ETF	0.00%	20	$532	$23.2M	0.95%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	20,314	$540K	$40.55B	0.17%
DFAU	Dimensional - US Core Equity Market ETF	0.00%	3,011	$80K	$10.37B	0.12%
DFUS	Dimensional - US Equity Market ETF	0.00%	5,798	$154K	$18.51B	0.09%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	21,833	$595K	$80.22B	0.03%
IWV	iShares Russell 3000 ETF	0.00%	6,413	$175K	$17.30B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.00%	10,304	$276K	$37.50B	0.03%
VTHR	Vanguard Russell 3000 ETF	0.00%	1,301	$45K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	542,046	$18.9M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	2,851	$135K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	245	$12K	$1.29B	0.17%
DFUV	Dimensional - US Marketwide Value ETF	0.00%	112	$3K	$13.28B	0.21%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	1	$40	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	5	$134	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	8	$228	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	10	$262	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	11	$311	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	10	$259	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	6	$171	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	5	$129	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	2	$57	$9.3M	0.12%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	26	$1K	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	952	$45K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	4	$217	$337.7M	0.32%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	21,833	$47K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	21,833	$14K	$3.91B	0.07%

PreviousPage 2 of 2

About RIGL ETF Exposure

Rigel Pharmaceuticals, Inc. (RIGL) is held by 87 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 469.4M, RIGL is a widely held institutional stock. The stock currently trades at $25.86. Investors can gain exposure to RIGL through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold RIGL, sorted by portfolio weight.